Evidence map›Paper›PMID 41628668›Full record

ArticleJournal of substance use and addiction treatment2026

Tailoring of a chronic pain self-management intervention for individuals with opioid use disorder in office-based addiction treatment.

Megan E Hamm, Ramona Emerson, Shari S Rogal, Hailey W Bulls, Shannon M Nugent, Alana Anderson, Samantha Nash, Melessa Salay, Erin L Winstanley, Flor de Abril Cameron and 9 more

Abstract read
In one paragraph

Article in Journal of substance use and addiction treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Megan E HammCenter for Biostatistics and Qualitative Methodology, University of Pittsburgh, Pittsburgh, PA, United States of America. Electronic address: Mehst52@pitt.edu.
Ramona EmersonSchool of Nursing, University of Pennsylvania, Philadelphia, PA, United States of America.
Shari S RogalDepartments of Medicine and Surgery, University of Pittsburgh, Pittsburgh, PA, United States of America; Center for Healthcare Evaluation, Research, and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, United States of America.
Hailey W BullsDepartment of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, AL, United States of America.
Shannon M NugentDepartment of Psychiatry, Oregon Health & Science University, Portland, OR, United States of America; Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, OR, United States of America.
Alana AndersonDivision of General Internal Medicine, Department of Medicine, Oregon Health and Science University, Portland, OR, United States of America.
Samantha NashDepartment of Behavioral Medicine and Psychiatry, West Virginia University, Morgantown, WV, United States of America.
Melessa SalayDivision of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States of America; Department of Behavioral and Community Health Sciences, University of Pittsburgh School of Public Health, Pittsburgh, PA, United States of America.
Erin L WinstanleyDivision of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States of America.
Flor de Abril CameronCenter for Biostatistics and Qualitative Methodology, University of Pittsburgh, Pittsburgh, PA, United States of America.
William DeMonteClinical Psychologist, Virginia Mason Franciscan Health, Tacoma, WA, United States of America.
Promiti DebiDivision of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States of America.
Lyn Yuen ChooPrescription Drug Misuse Education and Research (PREMIER) Center, University of Houston, Houston, TX, United States of America; Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, Houston, TX, United States of America.
Brian ChanDivision of General Internal Medicine & Geriatrics, Addiction Medicine Section, Oregon Health & Science University, Portland, OR, United States of America; Central City Concern, Portland, OR, United States of America.
Eric WeintraubSchool of Medicine, University of Maryland, College Park, MD, United States of America.
Rachel L BachrachAddiction Center, Department of Psychiatry, University of Michigan Medical School, Ann Arbor, MI, United States of America.
Dorothy van OppenDepartment of Behavioral Medicine and Psychiatry, Rockefeller Neuroscience Institute, West Virginia University School of Medicine, Morgantown, WV, United States of America.
Karlyn A EdwardsDivision of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States of America.
Jessica S MerlinSection of Palliative and Pain Research, Division of Palliative Medicine, The Ohio State University, Columbus, OH, United States of America.

Funding

Tailored Retention and Engagement for Equitable Treatment of OUD and Pain (TREETOP)RM1DA055311 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HAMM, MEGAN, MERLIN, JESSICA S · 2021 to 2025
$12.7M
Mentoring the next generation of researchers at the intersection of opioid use disorder and chronic painK24DA056837 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Megan Hamm, Jessica S Merlin · 2023 to 2026
$771k
NIDA NIH HHS K24 DA056837NIDA NIH HHS RM1 DA055311
6 · The paper itself

Abstract

introductionOffice-based opioid treatment with buprenorphine for opioid use disorder (OBOT-BUP) is most effective when patients are retained in treatment long-term, but average treatment duration is less than 6 months. Up to two thirds of individuals with opioid use disorder (OUD) have chronic pain. Treatment of chronic pain in OBOT-BUP settings could improve retention in OBOT-BUP programs. Therefore, this study qualitatively assessed how to tailor pain self-management (PSM) to people with co-occurring chronic pain and OUD in OBOT-BUP settings.

methodsThis study takes a Qualitative Description approach to data collection and interpretation. We conducted semi-structured qualitative interviews with 61 participants (23 clinicians/clinic staff and 38 patients) at OBOT-BUP clinics regarding experiences with chronic pain and its treatment, experiences with opioid use disorder and its treatment, and their thoughts the desirability, feasibility, and modification of a previously developed PSM program for patients with comorbid chronic pain and opioid use disorder. Interviews were coded using a primarily inductively developed codebook, and coding was used to conduct a thematic analysis of interview transcripts.

resultsParticipants generally reacted positively to the PSM program as presented. We identified 4 themes in the data that could affect implementation of PSM, and/or that suggested modifications that should be made to the program. (1) Patients reported relying on a wide array of treatment modalities, bolstering the case for use of PSM, but also sometimes expressing resistance to the idea if past attempts at PSM components had been unsuccessful. (2) Patients' prior experiences of stigma related to OUD negatively impacted willingness to participate in a PSM intervention. (3) Effective pain management using buprenorphine was regarded as a vital companion to PSM in patients with chronic pain and OUD. (4) Participants identified several aspects of PSM implementation that would be important, including individual sessions, peer-led group sessions, and remote visits.

conclusionsParticipants reported interest in PSM, but also reluctance based in concerns about efficacy and/or fear of stigma. We identified several strategies to respond to these concerns, including positioning PSM as an evidence-based strategy that works adjunctive to buprenorphine, and directly addressing pain/OUD stigma.

Indexed as

Chronic PainOpioid-Related DisordersSelf-ManagementAdultBuprenorphineFemaleHumansMaleMiddle AgedOpiate Substitution TreatmentQualitative ResearchBuprenorphineChronic painOffice-based buprenorphine treatment for opioid use disorderOpioid use disorderPain self-managementQualitative methods

Identifiers

PMID41628668
PMCPMC13371462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.